FIELD: medicine.
SUBSTANCE: proposed are compositions containing combinations of a compound by the formula (I) and one or more immune checkpoint inhibitors for treatment of cancer. Some implementations relate to methods for treating cancer by co-administration of a compound by the formula (I) and one or more immune checkpoint inhibitors to a subject in need thereof. Some implementations relate to methods for treating cancer by means of co-administration of a compound by the formula (I) and plinabulin to a subject in need thereof.
EFFECT: technical result of the invention is production of compositions applicable in treatment of cancer.
45 cl, 4 dwg, 9 ex
| Title |
Year |
Author |
Number |
| ANTITUMOR COMBINATION OF CHIDAMIDE AND CELECOXIB |
2019 |
- Chen, Jia-Shiong
- Yang, Mu-Hsuan
- Chou, Cheng-Han
- Wu, Yi-Hong
- Chu, Sz-Hao
- Chao, Ye-Su
- Chen, Chia-Nan
|
RU2811733C1 |
| NOVEL APPROACH TO CANCER TREATMENT USING IMMUNOMODULATION |
2016 |
- Mehta, Vimal D.
- Rastelli, Luca
- Sapra, Aparna Katoch
|
RU2817047C2 |
| IMMUNE RESPONSE PRESERVATION DURING CHEMOTHERAPEUTICAL SHEMES |
2017 |
- Sorrentino, Jessica A.
- Lai, Anne Y.
- Strum, Jay C.
- Roberts, Patrick, Joseph
|
RU2779478C2 |
| IMMUNE-MODIFYING PARTICLES FOR CANCER TREATMENT |
2019 |
|
RU2794261C2 |
| PEPTIDES IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS FOR USE IN TREATING CANCER |
2020 |
- Kholst, Peter Jokhannes
- Akselsson, Lena
- Andersson, Tommi
|
RU2826955C2 |
| TYPES OF COMBINATION THERAPY FOR TREATING CANCER |
2021 |
- Zhai, Yifan
- Yang, Dajun
- Wang, Guangfeng
- Qiu, Miaozhen
- Luo, Fan
|
RU2816314C1 |
| COMPOSITIONS CONTAINING NAPHTHYRIDINE DERIVATIVES AND ALUMINUM-CONTAINING AUXILIARY AGENT, INTENDED FOR USE IN TREATMENT OF SOLID TUMORS |
2018 |
- Kuk, Majkl
- Kasibkhatla, Skhajladzha
- Miller, Endryu T.
- U, Tom Yao-Khsiang
|
RU2787157C2 |
| NEW APPROACH TO TREATING CANCER WITH APPLICATION OF IMMUNOMODULATION |
2016 |
- Mehta, Vimal D.
- Rastelli, Luca
- Sapra, Aparna Katoch
|
RU2711380C2 |
| USE OF THE PLINABULIN IN COMBINATION WITH THE IMMUNE RESPONSE CONTROL POINT INHIBITORS |
2016 |
- Khuan Lan
- Li Gloriya Tsi-Ji
|
RU2723021C2 |
| COMBINATION OF IMMUNE CHECKPOINT MODULATOR AND COMPLEX CONTAINING CELL-PENETRATING PEPTIDE, CARGO MOLECULE, AND TLR PEPTIDE AGONIST FOR MEDICAL USE |
2017 |
- Deruazi Madikha
- Belnu Elodi
|
RU2748378C2 |
